Significance The antiviral lectin cyanovirin-N (CV-N) is shown to have potent activity against the syndromecoronavirus 2 (SARS-CoV-2) virus. CV-N showed improved binding and potency against more recent SARS-CoV-2 variants of… Click to show full abstract
Significance The antiviral lectin cyanovirin-N (CV-N) is shown to have potent activity against the syndromecoronavirus 2 (SARS-CoV-2) virus. CV-N showed improved binding and potency against more recent SARS-CoV-2 variants of concern and is shown to be able to reduce the severity of SARS-CoV-2 infections in test animals. The mechanism of action for CV-N is distinct from that of currently used anti-COVID therapeutics or from common vaccine targets on the receptor binding domain. CV-N is a potential broad-spectrum agent against infection from SARS-CoV-2.
               
Click one of the above tabs to view related content.